Company intelligence / Profile preview

SeromYx Systems, Inc.

Ownership: Private
Development stage: Commercial

Overview

SeromYx provides high-throughput functional and biophysical profiling of antibodies using its proprietary Systems Serology platform. The company supports pharmaceutical and biotechnology partners in vaccine and therapeutic antibody development by identifying correlates of protection, optimizing lead selection, supporting regulatory filings with robust data packages, and providing mechanistic insights into immune responses. Their work has contributed to the development of COVID19 monoclonal antibodies and vaccines for infectious diseases[1][2][4].

Therapeutic areas: OncologyImmunologyNeurologyInfectious Diseases
Modalities: Monoclonal antibodyVaccine (as a product class analyzed, not developed in-house)Biologic
Industry: Contract Research Organization

Partnerships

Not explicitly listed; works with major pharmaceutical/biotech companies as clients on a fee-for-service basis.

Beyond the preview

Go deeper on SeromYx Systems, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SeromYx Systems, Inc..

Explore the full profile